FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3080857519> ?p ?o ?g. }

• W3080857519 endingPage "27" @default.
• W3080857519 startingPage "19" @default.
• W3080857519 abstract "BackgroundHydroxychloroquine or chloroquine with or without azithromycin have been widely promoted to treat coronavirus disease 2019 (COVID-19) following early in vitro antiviral effects against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).ObjectiveThe aim of this systematic review and meta-analysis was to assess whether chloroquine or hydroxychloroquine with or without azithromycin decreased COVID-19 mortality compared with the standard of care.Data sourcesPubMed, Web of Science, Embase Cochrane Library, Google Scholar and MedRxiv were searched up to 25 July 2020.Study eligibility criteriaWe included published and unpublished studies comparing the mortality rate between patients treated with chloroquine or hydroxychloroquine with or without azithromycin and patients managed with standard of care.ParticipantsPatients ≥18 years old with confirmed COVID-19.InterventionsChloroquine or hydroxychloroquine with or without azithromycin.MethodsEffect sizes were pooled using a random-effects model. Multiple subgroup analyses were conducted to assess drug safety.ResultsThe initial search yielded 839 articles, of which 29 met our inclusion criteria. All studies except one were conducted on hospitalized patients and evaluated the effects of hydroxychloroquine with or without azithromycin. Among the 29 articles, three were randomized controlled trials, one was a non-randomized trial and 25 were observational studies, including 11 with a critical risk of bias and 14 with a serious or moderate risk of bias. After excluding studies with critical risk of bias, the meta-analysis included 11 932 participants for the hydroxychloroquine group, 8081 for the hydroxychloroquine with azithromycin group and 12 930 for the control group. Hydroxychloroquine was not significantly associated with mortality: pooled relative risk (RR) 0.83 (95% CI 0.65–1.06, n = 17 studies) for all studies and RR = 1.09 (95% CI 0.97–1.24, n = 3 studies) for randomized controlled trials. Hydroxychloroquine with azithromycin was associated with an increased mortality (RR = 1.27; 95% CI 1.04–1.54, n = 7 studies). We found similar results with a Bayesian meta-analysis.ConclusionHydroxychloroquine alone was not associated with reduced mortality in hospitalized COVID-19 patients but the combination of hydroxychloroquine and azithromycin significantly increased mortality." @default.
• W3080857519 created "2020-09-01" @default.
• W3080857519 creator A5046548178 @default.
• W3080857519 creator A5048207546 @default.
• W3080857519 creator A5050856217 @default.
• W3080857519 creator A5056513056 @default.
• W3080857519 creator A5065404277 @default.
• W3080857519 creator A5072168949 @default.
• W3080857519 date "2021-01-01" @default.
• W3080857519 modified "2023-10-17" @default.
• W3080857519 title "Effect of hydroxychloroquine with or without azithromycin on the mortality of coronavirus disease 2019 (COVID-19) patients: a systematic review and meta-analysis" @default.
• W3080857519 cites W1898915641 @default.
• W3080857519 cites W1964435302 @default.
• W3080857519 cites W1981680557 @default.
• W3080857519 cites W2104657845 @default.
• W3080857519 cites W2107328434 @default.
• W3080857519 cites W2108116635 @default.
• W3080857519 cites W2126930838 @default.
• W3080857519 cites W2150491173 @default.
• W3080857519 cites W2580356750 @default.
• W3080857519 cites W2768181348 @default.
• W3080857519 cites W2975424845 @default.
• W3080857519 cites W2999629617 @default.
• W3080857519 cites W3009577418 @default.
• W3080857519 cites W3010930696 @default.
• W3080857519 cites W3016626550 @default.
• W3080857519 cites W3018057581 @default.
• W3080857519 cites W3018307241 @default.
• W3080857519 cites W3018724080 @default.
• W3080857519 cites W3019682307 @default.
• W3080857519 cites W3020239101 @default.
• W3080857519 cites W3020506420 @default.
• W3080857519 cites W3022358203 @default.
• W3080857519 cites W3023082818 @default.
• W3080857519 cites W3023250042 @default.
• W3080857519 cites W3023346879 @default.
• W3080857519 cites W3023564114 @default.
• W3080857519 cites W3023908803 @default.
• W3080857519 cites W3024558861 @default.
• W3080857519 cites W3025679229 @default.
• W3080857519 cites W3026480087 @default.
• W3080857519 cites W3026749347 @default.
• W3080857519 cites W3030573714 @default.
• W3080857519 cites W3033571730 @default.
• W3080857519 cites W3033884900 @default.
• W3080857519 cites W3034165774 @default.
• W3080857519 cites W3034381722 @default.
• W3080857519 cites W3035256826 @default.
• W3080857519 cites W3036181717 @default.
• W3080857519 cites W3036432657 @default.
• W3080857519 cites W3037845546 @default.
• W3080857519 cites W3040366309 @default.
• W3080857519 cites W3041580639 @default.
• W3080857519 cites W3042021285 @default.
• W3080857519 cites W3042126419 @default.
• W3080857519 cites W3043308024 @default.
• W3080857519 cites W3044118599 @default.
• W3080857519 cites W3044623713 @default.
• W3080857519 cites W3045220852 @default.
• W3080857519 cites W3131805996 @default.
• W3080857519 doi "https://doi.org/10.1016/j.cmi.2020.08.022" @default.
• W3080857519 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7449662" @default.
• W3080857519 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32860962" @default.
• W3080857519 hasPublicationYear "2021" @default.
• W3080857519 type Work @default.
• W3080857519 sameAs 3080857519 @default.
• W3080857519 citedByCount "207" @default.
• W3080857519 countsByYear W30808575192020 @default.
• W3080857519 countsByYear W30808575192021 @default.
• W3080857519 countsByYear W30808575192022 @default.
• W3080857519 countsByYear W30808575192023 @default.
• W3080857519 crossrefType "journal-article" @default.
• W3080857519 hasAuthorship W3080857519A5046548178 @default.
• W3080857519 hasAuthorship W3080857519A5048207546 @default.
• W3080857519 hasAuthorship W3080857519A5050856217 @default.
• W3080857519 hasAuthorship W3080857519A5056513056 @default.
• W3080857519 hasAuthorship W3080857519A5065404277 @default.
• W3080857519 hasAuthorship W3080857519A5072168949 @default.
• W3080857519 hasBestOaLocation W30808575191 @default.
• W3080857519 hasConcept C126322002 @default.
• W3080857519 hasConcept C168563851 @default.
• W3080857519 hasConcept C203014093 @default.
• W3080857519 hasConcept C2777425658 @default.
• W3080857519 hasConcept C2778048844 @default.
• W3080857519 hasConcept C2778907293 @default.
• W3080857519 hasConcept C2779123688 @default.
• W3080857519 hasConcept C2779134260 @default.
• W3080857519 hasConcept C3008058167 @default.
• W3080857519 hasConcept C501593827 @default.
• W3080857519 hasConcept C524204448 @default.
• W3080857519 hasConcept C71924100 @default.
• W3080857519 hasConcept C86803240 @default.
• W3080857519 hasConcept C89423630 @default.
• W3080857519 hasConcept C95190672 @default.
• W3080857519 hasConceptScore W3080857519C126322002 @default.
• W3080857519 hasConceptScore W3080857519C168563851 @default.
• W3080857519 hasConceptScore W3080857519C203014093 @default.
• W3080857519 hasConceptScore W3080857519C2777425658 @default.

• next